News




Events

Jul 27, 2017 - Jul 27, 2017

Dissolution of the Association

>> Activities
>> Archive

Confirmed Speakers

von_Czettritz RA Peter von Czettritz
Preu Bohlig & Partner, München


"Challenges in the demarcation of material medical devices from medicinal products. Differences between legal and scientific assessment“
Dalrymple_75_100_72 Dr. Mike Dalrymple
MRC Technology, London, UK

“Hands on Translation: From Infinity to Beyond”
Cord-Dohrmann_CSO Dr. Cord Dohrmann
Evotec AG, Hamburg


"Accelerating Innovation through collaboration"
Hess_75_100_72 Dr. Jürgen Hess
Pharma Scientific Services Team (P.SS.T), München


"Medicines, medical devices and other healthcare products – differing regulatory systems"
Klebl Dr. Bert Klebl
Lead Discovery Center GmbH, Dortmund


"Science-to-Commercialization - a Max Planck Model for Early Innovative Drug Discovery"
Krawitz Dr. med. Peter Krawitz

Institut für Medizinische Genetik der Charité - Universitätsmedizin Berlin

"Genetalk- an approach to end the diagnostic odyssey for patients with rare genetic disorders"

Kusnierz_Glaz_75_100_72

Dr. med. Claus Kusnierz-Glaz
PricewaterhouseCoopers AG, Frankfurt

"Digital Medicine: from the App to Big Data"

Lindemann_75_100_72

Dr. Christian Lindemann
VOELKER & Partner, Rechtsanwälte Wirtschaftsprüfer Steuerberater mbB, Reutlingen

„From Science to Market – legal obstacles to product success”

Jochen-Maas-Portrait_2014 Prof. Dr. Jochen Maas
Sanofi-Aventis Deutschland GmbH, Frankfurt

"Personalized medicine – are there also approaches outside Oncology"?
Mitchell_web

Christi Mitchell
Highbury Ltd, Hitchin, UK

“Commercial Deal Structures and Recent Trends”

Natz Dr. Alexander Natz
EUCOPE, 
Brussels, Belgium

"Towards greater Data Transparency – Trends and Impact on Market Access in Europe"
Poehlchen_75_100_72

Dr. Martin Pöhlchen
Sinfonie Life Science Management GmbH, Planegg

"Big Data: Big Business - Big Failures?

Schoenwald Dr. Dieter Schönwald
TÜV SÜD Product Service GmbH, München

"Current and upcoming regulatory requirements for In-vitro Diagnostics in EU"
Steinberger Prof. Dr. med. Daniela Steinberger
bio.logis Group, Frankfurt

"Big Data in Human Genetics: Challenges and Chances for disruptive Business Models"
Thomas_Iain_web Dr. Iain Thomas
Cambridge Enterprise, Cambridge, UK


“The Infinite Value-Inflection Point: Making the Untransactable Transactable”
Zwicker_75_100_72

Dr. Jörk Zwicker
Zwicker Schnappauf & Partner, Patentanwälte | PartG mbB, München

“Patenting Biotech Inventions in the U.S. post Myriad and Mayo”